Come up with a name for your new list and we'll add to it:
Brabant Pharma was acquired by
Zogenix on October 27, 2014.
Brabant Pharma is a single purpose company developing an oral treatment ("Brabafen") suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of infancy). Brabaf…